Skip to content

Repligen RGEN Return on equity

Return on equity at other companies

TEC
Bio-TechneTECH
6.5%-3.9pp
Revvity logo
RevvityRVTY
3.2%-0.5pp
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
13.5%-0.2pp
Danaher logo
DanaherDHR
7.1%-0.1pp
Agilent Technologies logo
Agilent TechnologiesA
21.3%+2.4pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
2.5%+1.3pp

Other financials

Income statement

See full
Revenue$194.3M+14.8%
Gross profit$108.3M+18.5%
Operating income$15.9M+142%
Net income$8.3M+42.9%
EPS (diluted)$0.15+50.0%

Balance sheet

See full
Cash & equivalents$582.7M-16.4%
Total debt$687.6M+346%
Total equity$2.1B+6.0%
Total assets$2.9B+2.8%

Cash flow

See full
Operating cash flow$28.3M+88.6%
CapEx$4.7M+32.2%
Free cash flow$23.6M+106%

Valuation

See full
Market cap$7.45B-7.1%
Enterprise value$7.55B+2.1%
P/E144.9×
P/S10.1×-0.1×

Profitability

See full
Gross margin49.5%+2.7pp
Operating margin1.5%-14.0pp
Net margin17.1%-3.7pp
FCF margin21.2%+6.1pp

Returns & leverage

See full
Debt / equity0.3×+0.2×
Current ratio9.2×+2.4×

Where this comes from

Calculated from Repligen’s reported figures.

Based on trailing twelve months.

The official record: Repligen’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Repligen's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Repligen's return on equity?
Repligen (RGEN) reported return on equity of 2.5% in Q1 2026.
How has Repligen's return on equity changed year-over-year?
Repligen's return on equity increased by 316.0% year-over-year, from -1.2% to 2.5%.
What is the long-term trend for Repligen's return on equity?
Over 4 years (2020 to 2025), Repligen's return on equity has grown at a -15.2% compound annual growth rate (CAGR), from 4.6% to 2.4%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.